Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

1.5K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

1.5K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.5K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

2.0K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
2.0K
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

1.5K
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
1.5K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

579
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
579
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

1.2K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact on postoperative outcomes of intraoperative fluid management strategies during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2023
Same author

Discrepancy in prevalence of Huntington's disease in two Swedish regions.

Acta neurologica Scandinavica·2017
Same author

Glucocorticoid receptor expression and binding capacity in patients with burn injury.

Acta anaesthesiologica Scandinavica·2015
Same author

Cerebral oxygen saturation during pulsatile and non-pulsatile cardiopulmonary bypass in patients with carotid stenosis.

Perfusion·2015
Same author

Real-time ventilation and perfusion distributions by electrical impedance tomography during one-lung ventilation with capnothorax.

Acta anaesthesiologica Scandinavica·2015
Same author

Adrenaline increases blood-brain-barrier permeability after haemorrhagic cardiac arrest in immature pigs.

Acta anaesthesiologica Scandinavica·2014

Related Experiment Video

Updated: Apr 16, 2026

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
09:47

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique

Published on: April 26, 2015

16.5K

Milrinone and esmolol decrease cardiac damage after resuscitation from prolonged cardiac arrest.

F Zoerner1, F Lennmyr, L Wiklund

  • 1Department of Surgical Sciences, Section of Anesthesiology and Intensive Care Medicine, Uppsala University Hospital, Uppsala, Sweden; Department of Operative and Intensive Care Medicine, Hallands Hospital Halmstad, Halmstad, Sweden.

Acta Anaesthesiologica Scandinavica
|March 20, 2015
PubMed
Summary
This summary is machine-generated.

A new drug combination including milrinone, esmolol, and vasopressin reduced cardiac damage during cardiopulmonary resuscitation (CPR) in piglets. However, this treatment did not improve survival rates after cardiac arrest (CA).

More Related Videos

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
08:19

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs

Published on: July 12, 2022

3.7K
Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest
07:18

Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest

Published on: April 14, 2023

2.5K

Related Experiment Videos

Last Updated: Apr 16, 2026

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
09:47

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique

Published on: April 26, 2015

16.5K
Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
08:19

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs

Published on: July 12, 2022

3.7K
Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest
07:18

Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest

Published on: April 14, 2023

2.5K

Area of Science:

  • Cardiovascular Research
  • Pharmacology
  • Critical Care Medicine

Background:

  • Long-term survival after cardiac arrest (CA) due to shock-refractory ventricular fibrillation (VF) remains low.
  • There is a critical need for novel pharmacological interventions during cardiopulmonary resuscitation (CPR) to improve patient outcomes.
  • This study investigates hemodynamic parameters and cardiac damage during resuscitation from prolonged CA in piglets.

Purpose of the Study:

  • To compare the efficacy of a combination of milrinone, esmolol, and vasopressin against vasopressin alone in piglets undergoing CPR.
  • To evaluate the impact of the treatment regimen on hemodynamic variables and cardiac injury markers.
  • To assess the effect of the intervention on survival rates following cardiac arrest.

Main Methods:

  • 26 immature male piglets were subjected to 12 minutes of VF followed by 8 minutes of CPR.
  • The treatment group received intravenous boluses of vasopressin, esmolol, and milrinone, followed by further boluses and continuous esmolol infusion during reperfusion.
  • Control group received vasopressin and saline; both groups received defibrillation and vasopressin if Return of Spontaneous Circulation (ROSC) was not achieved. Hemodynamic variables and troponin I were recorded.

Main Results:

  • Troponin I levels, a marker of cardiac injury, were significantly lower in the treatment group compared to controls after 180 minutes of reperfusion (P<0.05).
  • The treatment group required less norepinephrine (P<0.01) and exhibited greater diuresis (P<0.01).
  • No significant difference in survival rates was observed between the treatment and control groups.

Conclusions:

  • The combination of milrinone, esmolol, and vasopressin effectively decreased cardiac injury during CPR compared to vasopressin alone.
  • While the drug combination showed benefits in reducing myocardial damage and improving hemodynamic parameters, it did not enhance overall survival in this model.
  • Further research is warranted to explore strategies for improving survival outcomes in conjunction with myocardial protection during CPR.